Sentences with phrase «conditioning programs on»

Not exact matches

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

The IMF has not changed its conditions to be part of the program and its decision is dependent on what European creditors propose, according to a source who did not want to be named due to the sensitivity of the situation.

However, progression of the condition can be properly controlled with interventions like those provided by Omada and the YMCA, which worked with the Centers for Medicare and Medicaid Innovation on the trial program.

During an interview with the conservative talk - radio host CL Bryant on Thursday, Louisiana Sen. Bill Cassidy said that while states could develop programs of their own, the bill mandated fair coverage for people with preexisting conditions.

CVS will extend use of Epic's EHR technology to its specialty care programs for managing complex and chronic medical conditions and rare diseases, the company announced on Friday.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tPrograms (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

Applicants must be without decent, safe and sanitary housing; Be unable to obtain a loan from other resources on terms and conditions that can reasonably be expected to meet; Agree to occupy the property as your primary residence; Have the legal capacity to incur a loan obligation; Meet citizenship or eligible noncitizen requirements; Not be suspended or debarred from participation in federal programs.

Also, on account of the uncertain economic conditions in 2009, there was a reduction to the employee stock purchase program (capping employee contributions at 5 % rather than 10 % of eligible compensation).

For more information on the standard SOMA securities lending program terms, please see: August 26, 1999 - Announcement of Change in Lending Limits for SOMA Securities Lending Program, September 7, 1999 - Revised SOMA Securities Lending Program — FAQs, and September 7, 1999 - Revised SOMA Securities Lending Program Terms and Condprogram terms, please see: August 26, 1999 - Announcement of Change in Lending Limits for SOMA Securities Lending Program, September 7, 1999 - Revised SOMA Securities Lending Program — FAQs, and September 7, 1999 - Revised SOMA Securities Lending Program Terms and CondProgram, September 7, 1999 - Revised SOMA Securities Lending Program — FAQs, and September 7, 1999 - Revised SOMA Securities Lending Program Terms and CondProgram — FAQs, and September 7, 1999 - Revised SOMA Securities Lending Program Terms and CondProgram Terms and Conditions.

Such risks and uncertainties include, but are not limited to: our ability to achieve our financial, strategic and operational plans or initiatives; our ability to predict and manage medical costs and price effectively and develop and maintain good relationships with physicians, hospitals and other health care providers; the impact of modifications to our operations and processes; our ability to identify potential strategic acquisitions or transactions and realize the expected benefits of such transactions, including with respect to the Merger; the substantial level of government regulation over our business and the potential effects of new laws or regulations or changes in existing laws or regulations; the outcome of litigation, regulatory audits, investigations, actions and / or guaranty fund assessments; uncertainties surrounding participation in government - sponsored programs such as Medicare; the effectiveness and security of our information technology and other business systems; unfavorable industry, economic or political conditions, including foreign currency movements; acts of war, terrorism, natural disasters or pandemics; our ability to obtain shareholder or regulatory approvals required for the Merger or the requirement to accept conditions that could reduce the anticipated benefits of the Merger as a condition to obtaining regulatory approvals; a longer time than anticipated to consummate the proposed Merger; problems regarding the successful integration of the businesses of Express Scripts and Cigna; unexpected costs regarding the proposed Merger; diversion of management's attention from ongoing business operations and opportunities during the pendency of the Merger; potential litigation associated with the proposed Merger; the ability to retain key personnel; the availability of financing, including relating to the proposed Merger; effects on the businesses as a result of uncertainty surrounding the proposed Merger; as well as more specific risks and uncertainties discussed in our most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.cigna.com as well as on Express Scripts» most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.express-scripts.com.

One official, who spoke on the condition of anonymity to discuss internal deliberations, said that Mr. Trump was sympathetic to the plight of the young immigrants, known as Dreamers — many have known life only in the United States and have few connections to the countries of their birth — but had been told by Justice Department lawyers that his predecessor's program would not survive a court challenge.

Royal Bank of Canada (RBC)(«RY» on TSX and NYSE) today announced the completion of its share repurchase program (the «Program»), as required by the conditions of the issuer bid exemption order issued to RBC by the Ontario Securities Commission on January 10, program (the «Program»), as required by the conditions of the issuer bid exemption order issued to RBC by the Ontario Securities Commission on January 10, Program»), as required by the conditions of the issuer bid exemption order issued to RBC by the Ontario Securities Commission on January 10, 2018...

For example, had increasing broadband adoption among low income households been a priority, the Government could have imposed a condition on the MTS transaction to require a program to be developed similar to those offered by TELUS and Rogers.

Many factors could cause BlackBerry's actual results, performance or achievements to differ materially from those expressed or implied by the forward - looking statements, including, without limitation: BlackBerry's ability to enhance its current products and services, or develop new products and services in a timely manner or at competitive prices, including risks related to new product introductions; risks related to BlackBerry's ability to mitigate the impact of the anticipated decline in BlackBerry's infrastructure access fees on its consolidated revenue by developing an integrated services and software offering; intense competition, rapid change and significant strategic alliances within BlackBerry's industry; BlackBerry's reliance on carrier partners and distributors; risks associated with BlackBerry's foreign operations, including risks related to recent political and economic developments in Venezuela and the impact of foreign currency restrictions; risks relating to network disruptions and other business interruptions, including costs, potential liabilities, lost revenues and reputational damage associated with service interruptions; risks related to BlackBerry's ability to implement and to realize the anticipated benefits of its CORE program; BlackBerry's ability to maintain or increase its cash balance; security risks; BlackBerry's ability to attract and retain key personnel; risks related to intellectual property rights; BlackBerry's ability to expand and manage BlackBerry ® World ™; risks related to the collection, storage, transmission, use and disclosure of confidential and personal information; BlackBerry's ability to manage inventory and asset risk; BlackBerry's reliance on suppliers of functional components for its products and risks relating to its supply chain; BlackBerry's ability to obtain rights to use software or components supplied by third parties; BlackBerry's ability to successfully maintain and enhance its brand; risks related to government regulations, including regulations relating to encryption technology; BlackBerry's ability to continue to adapt to recent board and management changes and headcount reductions; reliance on strategic alliances with third - party network infrastructure developers, software platform vendors and service platform vendors; BlackBerry's reliance on third - party manufacturers; potential defects and vulnerabilities in BlackBerry's products; risks related to litigation, including litigation claims arising from BlackBerry's practice of providing forward - looking guidance; potential charges relating to the impairment of intangible assets recorded on BlackBerry's balance sheet; risks as a result of actions of activist shareholders; government regulation of wireless spectrum and radio frequencies; risks related to economic and geopolitical conditions; risks associated with acquisitions; foreign exchange risks; and difficulties in forecasting BlackBerry's financial results given the rapid technological changes, evolving industry standards, intense competition and short product life cycles that characterize the wireless communications industry.

Those sweeteners are subject to conditions that include Juno agreeing to partner on select Celgene programs, and the biotech giant owning up to a maximum 30 % of Juno's common stock.

Clear / comprehensive Terms and Conditions — affiliates should easily understand where your program stands on trademark bidding, direct linking, downloadable applications, etc..

Additionally, it is difficult for the investor to verify the descriptions of how the tokens function based on the underlying program code (smart contract) outlined in the accompanying white papers or terms and conditions.

In response to shareholder feedback, the company revamped its executive compensation program by introducing a formulaic bonus scheme (which included metrics based on TSR, production, expenses, and margins), conditioning equity awards on performance metrics (relative TSR and absolute cash flow), and reducing Mr. Nichols» salary by one - third.

Examples of these risks, uncertainties and other factors include, but are not limited to the impact of: adverse general economic and related factors, such as fluctuating or increasing levels of unemployment, underemployment and the volatility of fuel prices, declines in the securities and real estate markets, and perceptions of these conditions that decrease the level of disposable income of consumers or consumer confidence; adverse events impacting the security of travel, such as terrorist acts, armed conflict and threats thereof, acts of piracy, and other international events; the risks and increased costs associated with operating internationally; our expansion into and investments in new markets; breaches in data security or other disturbances to our information technology and other networks; the spread of epidemics and viral outbreaks; adverse incidents involving cruise ships; changes in fuel prices and / or other cruise operating costs; any impairment of our tradenames or goodwill; our hedging strategies; our inability to obtain adequate insurance coverage; our substantial indebtedness, including the ability to raise additional capital to fund our operations, and to generate the necessary amount of cash to service our existing debt; restrictions in the agreements governing our indebtedness that limit our flexibility in operating our business; the significant portion of our assets pledged as collateral under our existing debt agreements and the ability of our creditors to accelerate the repayment of our indebtedness; volatility and disruptions in the global credit and financial markets, which may adversely affect our ability to borrow and could increase our counterparty credit risks, including those under our credit facilities, derivatives, contingent obligations, insurance contracts and new ship progress payment guarantees; fluctuations in foreign currency exchange rates; overcapacity in key markets or globally; our inability to recruit or retain qualified personnel or the loss of key personnel; future changes relating to how external distribution channels sell and market our cruises; our reliance on third parties to provide hotel management services to certain ships and certain other services; delays in our shipbuilding program and ship repairs, maintenance and refurbishments; future increases in the price of, or major changes or reduction in, commercial airline services; seasonal variations in passenger fare rates and occupancy levels at different times of the year; our ability to keep pace with developments in technology; amendments to our collective bargaining agreements for crew members and other employee relation issues; the continued availability of attractive port destinations; pending or threatened litigation, investigations and enforcement actions; changes involving the tax and environmental regulatory regimes in which we operate; and other factors set forth under «Risk Factors» in our most recently filed Annual Report on Form 10 - K and subsequent filings by the Company with the Securities and Exchange Commission.

Policy must be justified by «studies,» which typically focus on determinants that are more impersonal, particularly adverse economic conditions and insufficient government training programs, support services, or income benefits.

He isolated the treatment paradox: «If the alcoholic's ailment is a disease that causes an inability to abstain from drinking how can a program insist on voluntary abstention as a condition for treatment?»

Conservatives think that a large federal government with expensive programs becomes a burden on society that actually can't be sustained and creates worse conditions in the long run.

«The [FBI] official, who spoke on condition of anonymity, questioned the logic of the mapping program, reasoning that the wholesale plotting of Muslim communities - rather than zeroing in on suspected extremists - could drain counter-terrorism resources and alienate Muslim residents at a time when they are crucial to law enforcement efforts.»

Though the power of determination of the specific content on television remains with the local station management, the FCC has on different occasions offered suggestions on the types of programming that should be present in a station's schedule in order for the station to fulfill the conditions of its license.

When we read such proclamations of the intellect bent on showing the existential conditions of absolutely everything, we feel — quite apart from our legitimate impatience at the somewhat ridiculous swagger of the program, in view of what the authors are actually able to perform — menaced and negated in the springs of our innermost life.

I do nt think we are all born with an innate sense of right and wrong, we are wired differently and our conditioning can program us to walk through life with blinders on not seeing how immoral and wrong our behavior is... I loved this story.

On one level Christians who adopt this position develop program material that — in contrast to the media's expressions — tries to illumine the human condition, to ask meaningful religious questions, to rediscover religious truths, and even to create a new religious vocabulary that has meaning and power for the multitudes.

While a healthy diet, limiting sugar and artificial ingredients, and structured programs are all recommended to assist with the treatment of the condition, the truth is that coping with autism on your own can often be very difficult, regardless of whether it is you or a loved one facing...

The previous year he had been the hardest grinder on the Browns, arriving first for the off - season conditioning programs and leaving last, but now he was grimmer and more fiercely driven than ever.

In Shanahan's first - floor office, with the practice fields outside his window (at one point, in an early phase of the off - season strength and conditioning program, a group of players including quarterbacks Brian Hoyer and Matt Barkley stretched out on the field), he and Lynch studied candidates; Marathe and vice president of player personnel Adam Peters filtered in and out, in between projects and calls.

Frank put the teenage Bob on a rigorous conditioning program long before such regimens were common.

By solely relying on this energy system and ignoring the other energy systems in conditioning programs, athletes are missing a big component of conditioning.

As a freshman in the fall of 1998, Walton earned second - team All - Big East soccer honors, but a month after the season ended, the 5» 11» 185 - pounder joined the football team's winter conditioning program as a walk - on and by spring was on the roster as a cornerback.

If Rusty can institute a comprehensive training / nutrition / conditioning program that keeps players on the field, he'll be worth his weight in gold.

Several research studies have shown preseason conditioning programs that include plyometrics, weight training, and education on jumping mechanics decrease the risk for knee injuries significantly, especially in adolescent female athletes.

A lot is riding on the strength and conditioning program and the assistant coaches developing the underclassmen into better players next year.

I went a little mom on them and told them many high school and middle school programs were all about strength and conditioning like the NFL and Tom Shaw's gym, but that not much time was devoted to core strength and stretching.

Although these programs may look different depending on a child's age and fitness level, a fitness professional or physical therapist can design a safe strength and conditioning or injury prevention program.

If you are involved in a private youth sports program which plays on publicly - owned fields, diamonds, rinks, or courts, or are in local government, you have probably been hearing a lot lately about what is being dubbed the «power of the permit»: the authority municipalities and towns around the country are using to condition use of their athletic facilities by private programs on compliance with state concussion safety laws from which they would otherwise be exempt, or, in an increasing number of instances, to fill gaps in their state's law.

While helmets do not prevent concussions, replacing helmets that have reached or exceeded their useful life is an important step to keep young football players safe, especially as the replacement program will be combined with a strong educational campaign on concussion awareness, proper helmet fitting, and instruction on proper tackling, and receipt of the new helmets will be conditioned on coaches completing USA Football's basic coaching course.

Men who want to get rid of this condition often choose plastic surgery, take pills or go on a drastic weight loss programs.

The program's goal was to support developers that were breaking ground on new projects in Orland Park in the midst of unstable market conditions, officials said.

The National Athletic Trainers» Association 2014 position statement on the management of sport - related concussion [14] says all athletes should «ideally» undergo a preseason baseline assessment, but, that, at a minimum, athletes who are at a high risk of concussion based on their sport should be included in any baseline testing program, with athletes with a significant concussion history, or other relevant pre-existing condition, such as attention - deficit hyperactivity disorder, tested on an individual basis.

The belief that we can control our children on a very high level and somehow program or train or condition them for a successful life however we define it is extremely prevalent and takes many forms.

Replicating and Scaling Up Evidence - Based Home Visiting Programs: The Role of Implementation Research (PDF - 337 KB) Paulsell (2012) Encyclopedia on Early Childhood Development Discusses implementation research in the home visiting field, how research can be used to strengthen programs and improve targeted outcomes, and the conditions and supports necessary for effective implemePrograms: The Role of Implementation Research (PDF - 337 KB) Paulsell (2012) Encyclopedia on Early Childhood Development Discusses implementation research in the home visiting field, how research can be used to strengthen programs and improve targeted outcomes, and the conditions and supports necessary for effective implemeprograms and improve targeted outcomes, and the conditions and supports necessary for effective implementation.

The Lombard Park District does not discriminate against eligible residents who want to participate in programs on the basis of disabling conditions.

Additional research on the replication and scale - up of home visiting programs should be conducted to identify the conditions, processes, and supports associated with achieving and sustaining high - fidelity implementation.

This approach is very different from most parenting books and programs, in that it is based on an understanding of infant and toddler neuroscience, child psychology and development, as opposed to behavioral conditioning (which is based on animal training techniques.)

Carol Raphael, President and CEO of the Visiting Nurse Service of New York, the state's oldest and largest home care agency, said, «The Visiting Nurse Service of New York applauds Governor Cuomo's call for a thoughtful, collaborative approach to restructuring the State's Medicaid program; we are prepared to work with him and his Administration toward the enactment of policies that focus on coordinating care to the State's most vulnerable patients, who often suffer from multiple complex conditions.»

But the new program was contingent on REBNY and the Trades Council coming together with an agreement on prevailing wages, a condition that ultimately proved to be a death knell.